Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data

Author： Gerdtham U-G.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.22, Iss.1, 2004-01, pp. : 29-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Why is healthcare spending so high in the US?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 654, 2012-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Where is drug spending headed in the US for 2008?

By  

Inpharma, Vol. 1, Iss. 1630-1631, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Utilisation of Foreign Clinical Data in Japanese New Drug Approval Review: On What Basis Did the Regulatory Agency Accept Them?

By Shunsuke Ono  

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 3, 2004-01 ,pp. : 159-165

Adis International

Access to resources Recommend Favorite

A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?

By Hill S.  

PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. : 761-767

Adis International

Access to resources Recommend Favorite

Is reducing antidepressant spending the right approach?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 307, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite